RxDoctor Payments Data

Caroline Garvin

Psychiatric/Mental Health · Nashville, TNNPI 1740945351

Payments from drug & device makers

$1,594in general payments, 2019–2025

Across 96 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$317
  • Johnson & Johnson$221
  • Supernus Pharmaceuticals, Inc.$199
  • AbbVie$193
  • Teva Pharmaceuticals USA, Inc.$149
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$136
  • plus $380 from 7 others

What the payments were for

  • Food & beverage$1,594100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,594 in reported general payments places this provider in the 65th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$8,672
Medicare patients
16
Services billed
86

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate38$86,997
Aripiprazole21$1,185
Fluvoxamine Maleate27$1,005
Quetiapine Fumarate45$1,003
Benztropine Mesylate28$553
Bupropion XlBupropion Hcl41$543
Prazosin Hcl37$526
Desvenlafaxine Succinate ErDesvenlafaxine Succinate12$450
Olanzapine29$413
Duloxetine Hcl20$380
Trazodone Hcl35$304
Sertraline Hcl22$271
Haloperidol Decanoate12$269
Lamotrigine43$267
Escitalopram Oxalate18$245

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$221$86,99738 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →